Bill > HB2081

This bill establishes new reporting requirements for entities participating in the 340B Drug Pricing Program, a federal program that allows certain healthcare organizations to purchase outpatient prescription drugs at discounted prices. Specifically, the bill requires 340B-covered entities located in Missouri to submit a detailed annual report to the state's Department of Health and Senior Services by April 1st each year. The report must include comprehensive information about their drug purchases and dispensing, such as aggregate acquisition costs, payment amounts, number of claims, and how program savings are used. The bill defines key terms like "charity care" and "financially indigent" and mandates reporting on details including the number of low-income patients served, total operating costs, and charity care expenses. While the reported data will be collected by the department, it will remain confidential and not available for public inspection. The department must then aggregate this data and submit an electronic report to the state general assembly and publish it on their website by November 15th. Entities that fail to submit the required information will be subject to a fine of $1,000 per day that the report is overdue. This legislation aims to increase transparency and accountability for healthcare organizations participating in the 340B drug pricing program.

https://house.mo.gov/Bill.aspx?bill=HB2081&year=2026&code=R